Showing results (271-280 of 336) with videos related to

Sort By:
Pageof 34
British Journal of Cancer|July 9, 2004
Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trialR-D Hofheinz, J T Hartmann, A Willer, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 14, 2022
Symptom burden, psychosocial distress and palliative care needs in heart failure - A cross-sectional explorative pilot studyF Strangl, E Ischanow, A Ullrich, et al.
Breast Cancer Research and Treatment|December 25, 2009
Gene amplification in ductal carcinoma in situ of the breastL Burkhardt, T J Grob, I Hermann, et al.
British Journal of Cancer|December 4, 2003
Protracted infusional 5-fluorouracil plus high-dose folinic acid combined with bolus mitomycin C in patients with gastrointestinal cancer: a phase I/II dose escalation studyJ T Hartmann, K Oechsle, D Quietzsch, et al.
Bone Marrow Transplantation|May 1, 2012
Evaluation of BM cytomorphology after allo-SCT in patients with AMLM Christopeit, K Miersch, E Klyuchnikov, et al.
British Journal of Cancer|September 17, 2002
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study GroupC Kollmannsberger, O Rick, H Klaproth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 15, 2004
Residual tumor resection after high-dose chemotherapy in patients with relapsed or refractory germ cell cancerO Rick, C Bokemeyer, S Weinknecht, et al.
Der Urologe. Ausg. A|July 1, 1998
[Prognostic relevance of vena cava thrombosis in renal cell carcinoma]M A Kuczyk, G Köhn, K Höfner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study GroupC Kollmannsberger, J Beyer, R Liersch, et al.
ESMO Open|November 10, 2022
Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): a randomized, controlled trialN Harnischfeger, H M Rath, B Alt-Epping, et al.
Pageof 34